Love Hemp Group PLC Announces Directorate Changes

3 years ago

Directorate Changes - Garry Cook and Graham Mullis join BoardLONDON, UK / ACCESSWIRE / February 3, 2022 / Love Hemp…

Outset Medical to Report Fourth Quarter and Full Year 2021 Financial Results on Wednesday, February 16, 2022

3 years ago

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the…

Hologic Announces Financial Results for First Quarter of Fiscal 2022

3 years ago

– Revenue of $1.471 Billion, GAAP Diluted EPS of $1.95, and Non-GAAP Diluted EPS of $2.17 All Significantly Exceed Expectations…

NuGen M.D. Announces Closing of Debt Settlement

3 years ago

TORONTO, ON / ACCESSWIRE / February 2, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") is pleased to announce…

NeoGenomics Schedules its Fourth Quarter and Full Year 2021 Earnings Release for February 23, 2022

3 years ago

FT MYERS, FL / ACCESSWIRE / February 2, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…

Hemostemix Announces Financing

3 years ago

Calgary, Alberta--(Newsfile Corp. - February 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased…

Neovasc Announces Complete Dismissal of Securities Class Action Complaint with Prejudice

3 years ago

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - February 2, 2022) - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX:…

athenahealth Customers Outperformed Healthcare Industry in 2020 MIPS Quality Payment Program

3 years ago

More than 96% of athenaOne® clinicians received positive payment adjustments WATERTOWN, Mass.--(BUSINESS WIRE)--athenahealth, Inc., a leading provider of network-enabled software…

Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network

3 years ago

Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINKJUPITER, FL / ACCESSWIRE / February…

XVIVO Gains Regulatory Approval in China for PERFADEX(R) Plus – the Global Gold Standard for Lung Preservation

3 years ago

GOTHENBURG, SE / ACCESSWIRE / February 2, 2022 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)XVIVO Perfusion AB has gained regulatory…